REAL-WORLD EVIDENCE DEMONSTRATES COMPARABLE CLINICAL OUTCOMES OF SWITCHING FROM INSULIN GLARGINE 100 U/ML TO INSULIN GLARGINE 300 U/ML VS INSULIN DEGLUDEC IN T2D PATIENTS Article

Web of Science: 000425015800327
Industry Collaboration International Collaboration

Cited authors

  • Blonde, L.; Zhou, F. L.; Bosnyak, Z.; Westerbacka, J.; Gupta, V. E.; Sharma, R. K.; Bailey, T. S.

Authors

Publication date

  • 2018

Published in

Category

International Standard Serial Number (ISSN)

  • 1520-9156

Start page

  • A137

End page

  • A138

Volume

  • 20